Drugs / An'ningpai
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04511897 | Jan 2021 → Dec 2022 | bronchiectasis | Shanghai Pulmonary Hospital, Shanghai, China | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | An'ningpai | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04511897 ↗ |
| Route | Oral | “300 mg, oral, three times daily for 12 months.” NCT04511897 ↗ |